AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist

Forex

<p>BOSTON, Feb.</p> <p>The post <a href="https://forextv.com/top-news/aveo-oncology-announces-publication-of-long-term-survival-in-patients-with-relapsed-refractory-advanced-renal-cell-carcinoma-treated-with-tivozanib-analysis-of-the-phase-iii-tivo-3-trial-in-the-oncol/">AVEO Oncology Announces Publication of Long-

BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market

Forex

<p>MELVILEE, N.Y., Feb.</p> <p>The post <a href="https://forextv.com/top-news/biorestorative-therapies-announces-exercise-of-warrants-and-issuance-of-new-warrants-in-a-private-placement-for-8-1-million-gross-proceeds-priced-at-the-market/">BioRestorative Therapies Announces Exercise of Warrants and Issuance of New

Page 25 of 9784